Drug Type Recombinant protein |
Synonyms |
Target |
Mechanism SARS-CoV S protein inhibitors(SARS-CoV S protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Severe Acute Respiratory Syndrome | Preclinical | CN | 01 Apr 2005 |